Oppenheimer & CO Inc Bristol Myers Squibb CO Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oppenheimer & CO Inc holds 234,211 shares of BMY stock, worth $13.7 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
234,211
Previous 203,339 15.18%
Holding current value
$13.7 Million
Previous $8.44 Million 43.53%
% of portfolio
0.19%
Previous 0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$39.66 - $51.75 $1.22 Million - $1.6 Million
30,872 Added 15.18%
234,211 $12.1 Million
Q2 2024

Aug 07, 2024
SELL
$40.25 - $52.99 $624,277 - $821,874
-15,510 Reduced 7.09%
203,339 $8.44 Million
Q1 2024

May 06, 2024
BUY
$47.98 - $54.4 $1.27 Million - $1.44 Million
26,519 Added 13.79%
218,849 $11.9 Million
Q4 2023

Feb 13, 2024
SELL
$48.48 - $57.85 $739,513 - $882,443
-15,254 Reduced 7.35%
192,330 $9.87 Million
Q3 2023

Nov 07, 2023
SELL
$57.89 - $64.73 $1.43 Million - $1.59 Million
-24,621 Reduced 10.6%
207,584 $12 Million
Q2 2023

Aug 02, 2023
SELL
$63.71 - $70.74 $175,775 - $195,171
-2,759 Reduced 1.17%
232,205 $14.8 Million
Q1 2023

May 10, 2023
BUY
$65.71 - $74.53 $113,021 - $128,191
1,720 Added 0.74%
234,964 $16.3 Million
Q4 2022

Feb 07, 2023
SELL
$68.48 - $81.09 $713,013 - $844,309
-10,412 Reduced 4.27%
233,244 $16.8 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $2,617 - $1.55 Million
-20,135 Reduced 7.63%
243,656 $17.3 Million
Q2 2022

Aug 08, 2022
SELL
$72.62 - $79.98 $1.09 Million - $1.2 Million
-14,949 Reduced 5.36%
263,791 $20.3 Million
Q1 2022

May 12, 2022
BUY
$61.48 - $73.72 $606,869 - $727,690
9,871 Added 3.67%
278,740 $20.4 Million
Q4 2021

Feb 02, 2022
SELL
$53.63 - $62.52 $1.35 Million - $1.58 Million
-25,204 Reduced 8.57%
268,869 $16.8 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $772,582 - $904,980
13,057 Added 4.65%
294,073 $17.4 Million
Q2 2021

Aug 03, 2021
SELL
$61.91 - $67.42 $5.67 Million - $6.17 Million
-91,557 Reduced 24.57%
281,016 $18.8 Million
Q1 2021

May 10, 2021
SELL
$59.34 - $66.74 $791,773 - $890,511
-13,343 Reduced 3.46%
372,573 $23.5 Million
Q4 2020

Feb 11, 2021
BUY
$57.74 - $65.43 $776,025 - $879,379
13,440 Added 3.61%
385,916 $23.9 Million
Q3 2020

Nov 13, 2020
BUY
$57.43 - $63.64 $385,929 - $427,660
6,720 Added 1.84%
372,476 $22.5 Million
Q2 2020

Aug 11, 2020
SELL
$54.82 - $64.09 $675,656 - $789,909
-12,325 Reduced 3.26%
365,756 $21.5 Million
Q1 2020

May 08, 2020
BUY
$46.4 - $67.43 $650,806 - $945,773
14,026 Added 3.85%
378,081 $21.1 Million
Q4 2019

Feb 07, 2020
BUY
$49.21 - $64.19 $3.1 Million - $4.04 Million
62,958 Added 20.91%
364,055 $23.4 Million
Q3 2019

Oct 31, 2019
SELL
$42.77 - $50.71 $136,521 - $161,866
-3,192 Reduced 1.05%
301,097 $15.3 Million
Q2 2019

Aug 09, 2019
BUY
$44.62 - $49.34 $281,016 - $310,743
6,298 Added 2.11%
304,289 $13.8 Million
Q1 2019

Apr 24, 2019
SELL
$45.12 - $53.8 $370,525 - $441,805
-8,212 Reduced 2.68%
297,991 $14.2 Million
Q4 2018

Jan 29, 2019
SELL
$48.76 - $63.23 $1.74 Million - $2.26 Million
-35,746 Reduced 10.45%
306,203 $15.9 Million
Q3 2018

Oct 26, 2018
SELL
$55.19 - $62.25 $31,403 - $35,420
-569 Reduced 0.17%
341,949 $21.2 Million
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $123,141 - $153,482
-2,437 Reduced 0.71%
342,518 $19 Million
Q1 2018

May 01, 2018
BUY
$59.92 - $68.98 $122,836 - $141,409
2,050 Added 0.6%
344,955 $21.8 Million
Q4 2017

Feb 07, 2018
SELL
$59.94 - $65.35 $157,822 - $172,066
-2,633 Reduced 0.76%
342,905 $21 Million
Q3 2017

Nov 09, 2017
BUY
$55.23 - $63.74 $19.1 Million - $22 Million
345,538
345,538 $22 Million

Others Institutions Holding BMY

# of Institutions
2,529
Shares Held
1.47B
Call Options Held
28M
Put Options Held
30.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email